Simona Scheggi
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Dose-dependent modulation of social and motivational behavior by lurasidone in a rat model of social defeat.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: April 02, 2026
Sleep deprivation impairs information processing via dysregulation of chloride homeostasis in the prefrontal cortex.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
Faster and greater antidepressant response to intravenous ketamine in bipolar compared with unipolar treatment-resistant depression: Diagnostic and sex-related findings from a naturalistic study.
Journal: Psychiatry research
Published: January 19, 2026
Prefrontal 5α-reductase 2 mediates male-specific acute stress response.
Journal: Science advances
Published: January 22, 2025
Restorative properties of chronic lurasidone treatment on emotional dysfunction in rats exposed to chronic unavoidable stress: A role for medial prefrontal cortex - nucleus accumbens network.
Journal: Neuropharmacology
Published: October 30, 2024
Exploring persistence in animal models: The sinking platform test.
Journal: Journal of neuroscience methods
Published: September 05, 2024
A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?
Journal: Children (Basel, Switzerland)
Published: June 05, 2024
Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes.
Journal: Neuroscience and biobehavioral reviews
Published: May 23, 2024
Still controversial issues on assessing anhedonia in experimental modeling of depression.
Journal: Translational psychiatry
Published: May 18, 2024
Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans.
Journal: Phytotherapy research : PTR
Published: April 18, 2024
Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370].
Journal: Experimental neurology
Published: December 16, 2023
Last Updated: 09/26/2026